| Title | Author(s) | Year | View Count |
 | AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma | Xu, MZ; Chan, SW; Liu, AM; Wong, KF; Fan, ST; Chen, J; Poon, RT; Zender, L; Lowe, SW; Hong, W; Luk, JM | 2011 | 427 |
| Targeting YAP and Hippo signaling pathway in liver cancer | Liu, AM; Xu, MZ; Chen, J; Poon, RT; Luk, JM | 2010 | 460 |
| Circulating lamin B1 (LMNB1) biomarker detects early stages of liver cancer in patients | Sun, S; Xu, MZ; Poon, RT; Day, PJ; Luk, JM | 2010 | 381 |
| Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma | Liu, LX; Lee, NP; Chan, VW; Xue, W; Zender, L; Zhang, C; Mao, M; Dai, H; Wang, XL; Xu, MZ; Lee, TK; Ng, IO; Chen, Y; Kung, HF; Lowe, SW; Poon, RTP; Wang, JH; Luk, JM | 2009 | 367 |
| Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma | Xu, MZ; Yao, TJ; Lee, NPY; Ng, IOL; Chan, YT; Zender, L; Lowe, SW; Poon, RTP; Luk, JM | 2009 | 641 |
| Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma | Lee, NPY; Leung, KW; Cheung, N; Lam, BY; Xu, MZ; Sham, PC; Lau, GK; Poon, RTP; Fan, ST; Luk, JM | 2008 | 129 |
|
